Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors

American Journal of Transplantation

Volumn 16, Issue 12, 2016, Pages 3540-3547

  Anjum, S ^a   Muzaale, A D ^a   Massie, A B ^a,b   Bae, S ^a   Luo, X ^a   Grams, M E ^a,b   Lentine, K L ^c   Garg, A X ^d   Segev, D L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

clinical research practice; donors and donation: donor follow up; donors and donation: living; kidney transplantation nephrology

Indexed keywords

ADULT; AGE; ARTICLE; CONFIDENCE INTERVAL; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DONOR; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; SEX; STATISTICAL ANALYSIS; ADOLESCENT; CHRONIC KIDNEY FAILURE; COMPLICATION; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; NEPHRECTOMY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84994097478     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13917     Document Type: Article

References (41)

1. Mjoen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int 2014; 86: 162–167.
2. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311: 579–586.
3. Grams ME, Sang Y, Levey AS, et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2016; 374: 411–421.
4. Cherikh WS, Young CJ, Kramer BF, Taranto SE, Randall HB, Fan PY. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant 2011; 11: 1650–1655.
5. Kiberd BA. Estimating the long term impact of kidney donation on life expectancy and end stage renal disease. Transplant Res 2013; 2: 2.
6. Kiberd B, Tennankore K. Kidney donation and risk of ESRD. JAMA 2014; 312: 93.
7. Boudville N, Garg AX. End-stage renal disease in living kidney donors. Kidney Int 2014; 86: 20–22.
8. Bia MJ, Ramos EL, Danovitch GM, et al. Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 1995; 60: 322–327.
9. Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. The evaluation of living renal transplant donors: Clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1996; 7: 2288–2313.
10. Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 2007; 7: 2333–2343.
11. Shankland SJ, Pollak MR. A suPAR circulating factor causes kidney disease. Nat Med 2011; 17: 926–927.
12. Hayek SS, Sever S, Ko YA, et al. Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med 2015; 373: 1916–1925.
13. Kofman T, Audard V, Narjoz C, et al. APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair. Am J Kidney Dis 2014; 63: 816–819.
14. Clark EG, Knoll G, Bugeja A, Burns KD, Scofield RH. Lupus after kidney donation to an affected male relative. Transplantation 2015; 99: e27–e28.
15. Steiner RW, Ix JH, Rifkin DE, Gert B. Estimating risks of de novo kidney diseases after living kidney donation. Am J Transplant 2014; 14: 538–544.
16. Fehrman-Ekholm I, Norden G, Lennerling A, et al. Incidence of end-stage renal disease among live kidney donors. Transplantation 2006; 82: 1646–1648.
17. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6(5 Pt 2): 1228–1242.
18. Centers for Medicare and Medicaid Services website. [cited 2015 Apr 17]. Available from: http://www.cms.gov/Medicare/CMS-Forms/CMS-Forms/downloads/cms2728.pdf.
19. Longenecker JC, Coresh J, Klag MJ, et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000; 11: 520–529.
20. Cox C, Chu H, Schneider MF, Munoz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med 2007; 26: 4352–4374.
21. Louis TA, Zeger SL. Effective communication of standard errors and confidence intervals. Biostatistics 2009; 10: 1–2.
22. Steiner RW. Moving closer to understanding the risks of living kidney donation. Clin Transplant 2016; 30: 10–16.
23. Steiner RW. The Risks of Living Kidney Donation. N Engl J Med 2016; 374: 479–480.
24. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459–469.
25. United States Renal Data System (2014 Annual Data Report Reference Tables). [cited 2015 Aug 17]. Available from: http://www.usrds.org/reference.aspx.
26. Delmonico F; Council of the Transplantation S. A report of the Amsterdam Forum on the care of the live kidney donor: Data and medical guidelines. Transplantation 2005; 79(6 Suppl): S53–S66.
27. Krohn AG, Ogden DA, Holmes JH. Renal function in 29 healthy adults before and after nephrectomy. JAMA 1966; 196: 322–324.
28. Kasiske BL, Anderson-Haag T, Israni AK, et al. A prospective controlled study of living kidney donors: Three-year follow-up. Am J Kidney Dis 2015; 66: 114–124.
29. Roland AS, Hildreth EA, Sellers AM. Occult Primary Renal Disease in the Hypertensive Patient. Arch Intern Med 1964; 113: 101–110.
30. Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis 1995; 25: 207–221.
31. Hsu CY. Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective. Curr Opin Nephrol Hypertens 2002; 11: 267–272.
32. Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens 2001; 15: 99–106.
33. Iseki K, Ikemiya Y, Fukiyama K. Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int Suppl 1996; 55: S69–S71.
34. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800–805.
35. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13–18.
36. Marin R, Gorostidi M, Fernandez-Vega F, Alvarez-Navascues R. Systemic and glomerular hypertension and progression of chronic renal disease: The dilemma of nephrosclerosis. Kidney Int Suppl 2005; 99: S52–S56.
37. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005; 165: 923–928.
38. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–147.
39. Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 2013; 62: 245–252.
40. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154–2169.
41. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.